MoneyWorks4Me

Dr Reddys Laboratories informs about press release

31 Mar 2016 Evaluate

Dr Reddys Laboratories has informed about a press release dated March 31, 2016, titled ‘Dr. Reddy’s Laboratories Acquires the Rights to Investigational Anticancer Agent E7777 for U.S, Europe and Certain Emerging Markets from Eisai’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..